Related references
Note: Only part of the references are listed.Mechanisms of disease: Leukotrienes
Marc Peters-Golden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Leukotriene B4 enhances tumour necrosis factor-α-induced CCL27 production in human keratinocytes
N. Kanda et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2007)
Leukotriene B4 receptors BLT1 and BLT2:: Expression and function in human and murine mast cells
Katherine A. Lundeen et al.
JOURNAL OF IMMUNOLOGY (2006)
Overexpression of COX-2, Prostaglandin E Synthase-1 and Prostaglandin E Receptors in blood mononuclear cells and plaque of patients with carotid atherosclerosis:: Regulation by nuclear factor-κB
Almudena Gomez-Hernandez et al.
ATHEROSCLEROSIS (2006)
Expression of 5-lipoxygenase and leukotriene A4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability
Hong Qiu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Leukotriene B4 signaling through NF-κB-dependent BLT1 receptors on vascular smooth muscle cells in atherosclerosis and intimal hyperplasia
M Bäck et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
LTB4 stimulates growth of human pancreatic cancer cells via MAPK and PI-3 kinase pathways
WG Tong et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Leukotriene modifiers as potential therapeutics for cardiovascular disease
CD Funk
NATURE REVIEWS DRUG DISCOVERY (2005)
Association between 5-lipoxygenase expression and plaque instability in humans
F Cipollone et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Effects of a 5-lipoxygenase-activating protein inhibitor on biomarkers associated with risk of myocardial infarction - A randomized trial
H Hakonarson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Nuclear factor κB signaling in atherogenesis
MPJ de Winther et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
IgE- and IgE+Ag-mediated mast cell migration in an autocrine/paracrine fashion
J Kitaura et al.
BLOOD (2005)
Monocyte cyclooxygenase-2 overactivity: a new marker of subclinical atherosclerosis in asymptomatic subjects with cardiovascular risk factors?
O Beloqui et al.
EUROPEAN HEART JOURNAL (2005)
Canonical pathway of nuclear factor κB activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis
C Monaco et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke
A Helgadottir et al.
NATURE GENETICS (2004)
Role of leukotriene B4 receptors in the development of atherosclerosis:: Potential mechanisms
K Subbarao et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
NF-κB activation and Fas ligand overexpression in blood and plaques of patients with carotid atherosclerosis -: Potential implication in plaque instability
JL Martín-Ventura et al.
STROKE (2004)
Leukotriene B4 strongly increases monocyte chemoattractant protein-1 in human monocytes
L Huang et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm
L Zhao et al.
NATURE MEDICINE (2004)
Leukotriene B4 is an indirectly acting vasoconstrictor in guinea pig aorta via an inducible type of BLT receptor
M Bäck et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)
Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis
JH Dwyer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
5-Lipoxygenase and atherosclerosis
M Mehrabian et al.
CURRENT OPINION IN LIPIDOLOGY (2003)
BLT1 and BLT2:: the leukotriene B4 receptors
AM Tager et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2003)
Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis
R Spanbroek et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice
M Mehrabian et al.
CIRCULATION RESEARCH (2002)
Leukotriene B4 receptor antagonism reduces monocytic foam cells in mice
RJ Aiello et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E2-dependent plaque instability
F Cipollone et al.
CIRCULATION (2001)
A second leukotriene B4 receptor, BLT2:: A new therapeutic target in inflammation and immunological disorders
T Yokomizo et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
